Emergent BioSolutions (EBS) FCF Margin (2011 - 2026)
Emergent BioSolutions (EBS) posted FCF Margin of 88.00% for Q3 2026, up 90.47 percentage points from -2.47% a year earlier and up 64.95 percentage points from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) FCF Margin (2011 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, FCF Margin at Emergent BioSolutions was 29.02%, up 28.85 percentage points year-over-year; for FY2025, it came in at 21.11%, up 17.68 percentage points from FY2024.
- Annual FCF Margin has increased for three consecutive years, though with a five-year change of -3.94 percentage points (FY2020 to FY2025).
- In prior years, Emergent BioSolutions' FCF Margin was 3.43% in FY2024 (+28.01 pp), -24.58% in FY2023 (+10.64 pp), -35.22% in FY2022 (-40.64 pp) and 5.42% in FY2021 (-19.62 pp).
- The Q3 2026 figure stands as the highest quarterly FCF Margin in data going back to Q1 2011.
- On a year-over-year basis, FCF Margin increased in four of the last eight quarters, with an average year-over-year change of +10.91 percentage points.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q3 2023, with a gain of 161.58 percentage points; the weakest was Q3 2022, with a drop of 130.61 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was 23.05% (Q2 2026), -23.19% (Q1 2026) and 49.63% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 28.96% |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn | 88.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 88.00% |
| Jun 30, 2026 | 23.05% |
| Mar 31, 2026 | -23.19% |
| Dec 31, 2025 | 49.63% |
| Sep 30, 2025 | -2.47% |
| Jun 30, 2025 | 73.46% |
| Mar 31, 2025 | -6.66% |
| Dec 31, 2024 | -41.91% |
| Sep 30, 2024 | 50.34% |
| Jun 30, 2024 | 16.84% |
| Mar 31, 2024 | -24.43% |
| Dec 31, 2023 | 7.48% |
| Sep 30, 2023 | 17.52% |
| Jun 30, 2023 | -37.56% |
| Mar 31, 2023 | -121.18% |
| Dec 31, 2022 | 20.96% |
| Sep 30, 2022 | -144.06% |
| Jun 30, 2022 | -19.66% |
| Mar 31, 2022 | -22.80% |
| Dec 31, 2021 | 38.52% |
API Access
Emergent BioSolutions FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();